Tanaka, S., Batchelor, T. T., Iafrate, A. J., Dias-Santagata, D., Borger, D. R., Ellisen, L. W., . . . Chi, A. S. (2019). PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma. Acta Neuropathol Commun.
Chicago Style CitationTanaka, Shota, et al. "PIK3CA Activating Mutations Are Associated With More Disseminated Disease At Presentation and Earlier Recurrence in Glioblastoma." Acta Neuropathol Commun 2019.
Cita MLATanaka, Shota, et al. "PIK3CA Activating Mutations Are Associated With More Disseminated Disease At Presentation and Earlier Recurrence in Glioblastoma." Acta Neuropathol Commun 2019.
Atenció: Aquestes cites poden no estar 100% correctes.